Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression

Transplantation

Volumn 63, Issue 3, 1997, Pages 421-429

  Millan, Maria T ^a   Geczy, Carolyn ^b   Stuhlmeier, Karl M ^a   Goodman, David J ^a   Ferran, Christiane ^a   Bach, Fritz H ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b SCI Deaconess Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; MEMBRANE PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CELL LINE; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL ADHESION; CELL COMMUNICATION; CELL LINE; CHEMOKINE CCL2; COCULTURE TECHNIQUES; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MACROPHAGE ACTIVATION; MONOCYTES; PLASMINOGEN ACTIVATOR INHIBITOR 1; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031019714     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199702150-00016     Document Type: Article

References (56)

1. Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Inv 1992; 90: 1138.
2. Ross R. Atherosclerosis: a problem of the biology of the arterial wall cells and their interactions with blood components. Arteriosclerosis 1981; 1: 293.
3. Calderon TM, Factor SM, Hatcher VB, Berliner JA, Berman JW. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9: expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels. Lab Invest 1994; 70: 836.
4. Hosenpud JD. Immune mechanisms of cardiac allograft vasculopathy: an update. Transplant Immunol 1993; 1: 237.
5. Russell PS, Chase CM, Winn HJ, Calvin RB. Coronary atherosclerosis in transplanted mouse hearts. Am J Pathol 1994; 144: 260.
6. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52: 937.
7. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 199 3; 55: 857.
8. Geller RL, Bach FH, Turman MA, Casali P, Platt JL. Evidence that polyreactive antibodies are deposited in rejected discordant xenografts. Transplantation 1993; 55: 168.
9. Blakely ML, van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059.
10. Fryer JP, Leventhal JR, Dalmasso AP, et al. Beyond hyperacute rejection: accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets. Transplantation 1995; 59: 171.
11. Millan MT, Ferran C, Winkler H, et al. Xenotransplantation: problems and approaches. Transplant Proc 1994; 26: 3593.
12. Cotran RS, Pober JS. Endothelial activation and inflammation. Prog Immunol 1989; 8: 747.
13. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990; 50: 537.
14. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160.
15. Ferran C, Peuchmaur M, Desruennes M, et al. Implications of de novo ELAM-1 and VCAM-1 expression in human cardiac allograft rejection. Transplantation 1993; 55: 605.
16. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994; 55: 97.
17. Sica A, Wang JM, Colotta F, et al. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 1990; 144: 3034.
18. Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol 1994; 144: 975.
19. Pober J, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427.
20. DiCorleto PE, de la Motte CA. Characterization of the adhesion of the human monocytic cell line U937 to cultured endothelial cells. J Clin Invest 1985; 75: 1153.
21. Beekhuizen H, Corsel-van Tilburg AJ, van Furth R. Characterization of monocyte adherence to human macrovascular and microvascular endothelial cells. J Immunol 1990; 145: 510.
22. Wang J, Beekhuizen H, van Furth R. Surface molecules involved in the adherence of recombinant interferon-gamma (rIFN-g)-stimulated human monocytes to vascular endothelial cells. Clin Exp Immunol 1994; 95: 263.
23. Beekhuizen H, van Furth R. Monocyte adherence to human vascular endothelium. J Leukocyte Biol 1993; 54: 363.
24. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67.
25. Flo RW, Naess A, Lund-Johansen F, et al. Negative selection of human monocytes using magnetic particles covered by anti-lymphocyte antibodies. J Immunol Methods 1991; 137: 89.
26. Sundstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17: 565.
27. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26: 171.
28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 198 7; 162: 156.
29. Stuhlmeier KM, Csizmadia V, Cheng Q, Winkler H, Bach FH. Selective inhibition of E-selectin, ICAM-1 and VCAM in endothelial cells. Eur J Immunol 1994; 24: 2186.
30. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vivo and in vitro. Proc Natl Acad Sci USA 1992; 89: 4845.
31. Higuchi M, Aggarwal BB. Inhibition of ligand binding and anti-proliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant p60 and p80 receptors. Biochem Biophys Res Commun 1992; 182: 638.
32. Blakely ML, Van der Werf WJ, Hancock WW, Bach FH. Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with endothelial cell activation and mononuclear cell infiltration. Surg Forum 1993; 49: 399.
33. Goodman DJ, von Albertini M, Wilson A, Millan MT, Bach FH. Direct activation of porcine endothelial cells by human NK Cells. Transplantation 1996; 61: 763.
34. Takahashi M, Masuyama J, Ikeda U, et al. Induction of monocyte chemoattractant protein-1 synthesis in human monocytes during transendothelial migration in vitro. Circ Res 1995; 76: 750.
35. Hakkert BC, Rentenaar JM, van Mourik JA. Monocytes enhance the bidirectional release of type I plasminogen activator inhibitor by endothelial cells. Blood 1990; 76: 2272.
36. Hakkert BC, Rentenaar JM, van Mourik JA. Monocytes enhance endothelial von Willebrand factor release and prostacyclin production with different kinetics and dependency on intercellular contact between these two cell types. Br J Haematol 1992; 80: 495.
37. Lukacs NW, Strieter RM, Elner VM, Evanoff HL, Burdick M, Kunkel SL. Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1α during monocyte-endothelial cell interactions. Blood 1994; 83: 1174.
38. mb2) on human neutrophils. J Exp Med 1991; 173: 1493.
39. Takahashi M, Ikeda U, Masuyama J, et al. Involvement of adhesion molecules in human monocyte adhesion to and transmigration through endothelial cells in vitro. Atherosclerosis 1994; 108: 73.
40. Weber C, Erl W, Pietsch A, Strobel M, Ziegler-Heitbrock HW, Weber PC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 199 4; 14: 1665.
41. Meerschaert J, Furie MB. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1 and other ligands on endothelium. J Immunol 1995; 154: 4099.
42. Rollins SA, Evans MJ, Johnson KK, et al. Molecular and functional analysis of porcine E-selectin reveals a potential role in xenograft rejection. Biochem Biophys Res Commun 1994; 204: 763.
43. Hakkert BC, Kuijpers TW, Leeuwenberg JF, van Mourik JA, Roos D. Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: the contribution of CD18, ELAM-1 and VLA-4. Blood 1991; 78: 2721.
44. Leeuwenberg JF, Jeunhomme TM, Buurman WA. Role of ELAM-1 in adhesion of monocytes to activated human endothelial cells. Scand J Immunol 1992; 35: 335.
45. Murphy JF, McGregor JL. Two sites on P-selectin (the lectin and epidermal growth factor-like domains) are involved in the adhesion of monocytes to thrombin-activated endothelial cells. Biochem J 1994; 303: 619.
46. Murphy JF, Bordet JC, Wyler B, et al. The vitronectin receptor (alpha v beta 3) is implicated, in cooperation with P-selectin and platelet-activating factor, in the adhesion of monocytes to activated endothelial cells. Biochem J 1994; 304: 537.
47. McEver RP. GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 1991; 45: 156.
48. Maier JA, Barenghi L, Pagani F, Bradamante S, Comi P, Ragnotti G. The protective role of high-density lipoprotein on oxidized low-density-lipoprotein-induced U937/endothelial cell interactions. Eur J Biochem 1994; 221: 35.
49. DiCorleto PE, de la Motte CA. Role of cell surface carbohydrate moieties in monocytic cell adhesion to endothelium in vitro. J Immunol 1989; 143: 3666.
50. Zimmerman GA, Lorant DE, McIntyre TM, Prescott SM. Juxtacrine intercellular signaling: another way to do it. Am J Respir Cell Mol Biol 1993; 9: 573.
51. Singer SJ. Intercellular communication and cell-cell adhesion. Science 1992; 255:1671.
52. Decoster E, Vanhaesebroeck B, Vandenabeele P, Grooten J, Fiers W. Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor. J Biol Chem 1995; 270: 18473.
53. Luettig B, Decker T, Lohmann-Mattes ML. Evidence for the existence of two forms of membrane tumor necrosis factor: an integral protein and a molecule attached to its receptor. J Immunol 1989; 143: 4034.
54. Chuluyan HE, Issekutz AC. VLA-4 integrin can mediate CD11/ CD18-independent transendothelial migration of human monocytes. J Clin Invest 1993; 92: 2768.
55. Luscinskas FW, Kansas GS, Ding H, et al. Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, β1-integrins, and β2-integrins. J Cell Biol 1994; 125: 1417.
56. Altieri DC, Duperray A, Plescia J, Thornton GB, Languino LR. Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem 1995; 270: 696.